Dr. Bankole Johnson - 04 Oct 2021 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role: Chief Medical Officer
Signature: /s/ Bankole Johnson
Issuer symbol: ADIL
Transactions as of: 04 Oct 2021
Net transactions value: $0
Form type: 4
Filing time: 06 Oct 2021, 17:22:19 UTC
Next filing: 25 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ADIL	Common Stock	Sale		-200,000	-57%		148,246	04 Oct 2021	By En Fideicomiso De Mi Vida 11/23/2010 (Trust)	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ADIL	Warrant	Other		-150,000	-79%		39,714	04 Oct 2021	Common Stock	150,000		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	En Fideicomiso De Mi Vida 11/23/2010 (the "Trust") sold 200,000 shares of the issuer's common stock pursuant to a Stock Purchase Agreement dated as of October 1, 2021 (the "SPA"), for an aggregate purchase price of $200,000.
F2	Dr. Johnson is the trustee of the Trust.
F3	On October 4, 2021, Dr. Johnson sold warrants to purchase 150,000 shares of the issuer's common stock pursuant to the SPA, for an aggregate purchase price of $1,500. The warrants provide for an exercise price of $6.25 per share and expire five years after issuance.